Uli Alf Hacksell
Chairman bij ANNEXIN PHARMACEUTICALS AB
Vermogen: 147 265 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Uli Alf Hacksell
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 | |
| Public Company | Pharmaceuticals: Major | 26 | |
22
| Public Company | Pharmaceuticals: Major | 22 |
| Public Company | Pharmaceuticals: Major | 16 | |
| Public Company | Pharmaceuticals: Major | 14 | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
| Public Company | Pharmaceuticals: Major | 12 | |
| Public Company | Biotechnology | 12 | |
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden.
7
| Extinct | Pharmaceuticals: Major | 7 |
Astra Arcus AB
1
| Subsidiary | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Uli Alf Hacksell via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Founder Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Sales & Marketing | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Sales & Marketing | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Secretary Corporate Officer/Principal Sales & Marketing | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Director of Investments Director/Board Member Comptroller/Controller/Auditor | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Graduate Degree Graduate Degree | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Louisiana State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of Vermont | College/University | Doctorate Degree Doctorate Degree | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Founder | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Comptroller/Controller/Auditor | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman Corporate Officer/Principal | |
| Umea Universitet | College/University | Doctorate Degree Masters Business Admin | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| BIOARCTIC AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| INSPIREMD, INC. | Medical Specialties | Director/Board Member Chairman | |
| MENDUS AB | Biotechnology | Director of Finance/CFO Director/Board Member Chairman | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The private company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| Psoriasis+Creams Sweden AB | Chairman Director/Board Member | ||
| THERALINK TECHNOLOGIES, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Director of Finance/CFO Chief Executive Officer | |
Cinclus Pharma AG
 Cinclus Pharma AG BiotechnologyHealth Technology Cinclus Pharma AG is a Swiss Swedish pharmaceutical company founded in 2011. Cinclus Pharma is based in Basel, Switzerland. The private company is focused on bringing relief to people suffering from gastric acid related diseases, particularly gastroesophageal reflux disease (GERD). Cinclus Pharma's clinical stage drug candidate, linaprazan glurate, is a new approach to managing GERD and is showing promising results in acid control and lowering the cmax-value. The company was founded by experts in the field of GERD treatment with extensive experience from Astra and Astra Zeneca. | Biotechnology | Director/Board Member Director/Board Member | |
| SAVARA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Biotechnology | Founder Director/Board Member | |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Biotechnology | Chairman Director/Board Member | |
| Active Security Trading AB | Director/Board Member Chairman | ||
| Actinova AB | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Zweden | 25 |
| Verenigde Staten | 22 |
| Verenigd Koninkrijk | 2 |
| Denemarken | 2 |
| Israël | 2 |
Sectoraal
| Health Technology | 33 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Finance | 2 |
Operationeel
| Director/Board Member | 614 |
| Corporate Officer/Principal | 234 |
| Independent Dir/Board Member | 182 |
| Chairman | 154 |
| Chief Executive Officer | 107 |
Sterkste connecties
| Insiders | |
|---|---|
| Stig Lökke Pedersen | 40 |
| Garry Neil | 38 |
| Marie Helena Levander | 38 |
| Wenche Nelly A. Rolfsen Sandsborg | 36 |
| Bengt Åke Julander | 36 |
| Peter Sjöstrand | 35 |
| Isaac Blech | 32 |
| Sol Barer | 32 |
| Stig Lennart Hansson | 32 |
| Peter Greenleaf | 31 |
| Charles L. Rice | 30 |
| Anders Olof Adolf Ekblom | 27 |
| Laura Brege | 27 |
| Mary Gray | 27 |
| Gisela Marie Sitbon | 26 |
- Beurs
- Insiders
- Uli Alf Hacksell
- Bedrijfsconnecties
